A detailed history of Barclays PLC transactions in Stryker Corp stock. As of the latest transaction made, Barclays PLC holds 1,001,909 shares of SYK stock, worth $371 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
1,001,909
Previous 1,001,909 -0.0%
Holding current value
$371 Million
Previous $362 Million -0.0%
% of portfolio
0.1%
Previous 0.1%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$315.94 - $371.96 $12.3 Million - $14.5 Million
38,915 Added 4.04%
1,001,909 $362 Million
Q2 2024

Aug 14, 2024

SELL
$324.3 - $354.67 $38.5 Million - $42.2 Million
-118,851 Reduced 10.99%
962,994 $328 Million
Q1 2024

May 15, 2024

BUY
$293.94 - $358.71 $47 Million - $57.4 Million
159,898 Added 17.34%
1,081,845 $387 Million
Q4 2023

Feb 15, 2024

SELL
$253.85 - $299.46 $41.4 Million - $48.8 Million
-163,040 Reduced 15.03%
921,947 $276 Million
Q3 2023

Nov 07, 2023

BUY
$266.54 - $302.43 $109 Million - $124 Million
408,998 Added 60.5%
1,084,987 $296 Million
Q2 2023

Aug 03, 2023

BUY
$271.49 - $305.09 $81.5 Million - $91.6 Million
300,315 Added 79.94%
675,989 $206 Million
Q1 2023

May 04, 2023

SELL
$246.13 - $285.47 $36.8 Million - $42.7 Million
-149,559 Reduced 28.47%
375,674 $107 Million
Q4 2022

Feb 13, 2023

BUY
$205.51 - $253.93 $13.3 Million - $16.4 Million
64,679 Added 14.04%
525,233 $128 Million
Q3 2022

Nov 03, 2022

BUY
$189.27 - $231.83 $10.1 Million - $12.4 Million
53,484 Added 13.14%
460,554 $93.3 Million
Q2 2022

Aug 12, 2022

SELL
$194.09 - $276.37 $33.8 Million - $48.1 Million
-173,956 Reduced 29.94%
407,070 $81 Million
Q1 2022

May 16, 2022

SELL
$245.33 - $277.77 $169 Million - $191 Million
-688,752 Reduced 54.24%
581,026 $155 Million
Q4 2021

Feb 14, 2022

BUY
$236.63 - $276.44 $139 Million - $163 Million
588,854 Added 86.48%
1,269,778 $340 Million
Q3 2021

Nov 09, 2021

BUY
$248.9 - $280.09 $35.4 Million - $39.8 Million
142,137 Added 26.38%
680,924 $180 Million
Q2 2021

Aug 13, 2021

SELL
$242.95 - $267.0 $24.3 Million - $26.7 Million
-99,993 Reduced 15.65%
538,787 $140 Million
Q1 2021

May 13, 2021

BUY
$221.01 - $248.82 $54.7 Million - $61.5 Million
247,347 Added 63.19%
638,780 $156 Million
Q4 2020

Feb 11, 2021

BUY
$202.01 - $245.04 $5.41 Million - $6.56 Million
26,776 Added 7.34%
391,433 $95.9 Million
Q3 2020

Nov 12, 2020

BUY
$177.77 - $215.81 $17.4 Million - $21.1 Million
97,790 Added 36.64%
364,657 $76 Million
Q2 2020

Aug 12, 2020

BUY
$144.67 - $207.03 $9.18 Million - $13.1 Million
63,483 Added 31.21%
266,867 $48.1 Million
Q1 2020

May 13, 2020

SELL
$126.5 - $225.1 $37.9 Million - $67.4 Million
-299,316 Reduced 59.54%
203,384 $33.9 Million
Q4 2019

Feb 10, 2020

BUY
$197.98 - $220.53 $1.29 Million - $1.44 Million
6,518 Added 1.31%
502,700 $106 Million
Q3 2019

Nov 14, 2019

BUY
$205.4 - $221.82 $7.76 Million - $8.38 Million
37,795 Added 8.25%
496,182 $107 Million
Q2 2019

Aug 14, 2019

SELL
$180.24 - $205.58 $2.63 Million - $3 Million
-14,572 Reduced 3.08%
458,387 $94.2 Million
Q1 2019

May 15, 2019

SELL
$152.46 - $198.0 $18.9 Million - $24.6 Million
-124,284 Reduced 20.81%
472,959 $93.4 Million
Q4 2018

Feb 14, 2019

SELL
$145.0 - $178.65 $8.6 Million - $10.6 Million
-59,338 Reduced 9.04%
597,243 $93.6 Million
Q3 2018

Nov 14, 2018

SELL
$163.25 - $177.68 $284,055 - $309,163
-1,740 Reduced 0.26%
656,581 $117 Million
Q2 2018

Aug 14, 2018

SELL
$155.17 - $179.78 $41.6 Million - $48.1 Million
-267,826 Reduced 28.92%
658,321 $111 Million
Q1 2018

May 15, 2018

BUY
$148.01 - $168.91 $30.2 Million - $34.5 Million
204,221 Added 28.29%
926,147 $149 Million
Q4 2017

Feb 14, 2018

BUY
$143.51 - $159.74 $29.9 Million - $33.3 Million
208,597 Added 40.64%
721,926 $112 Million
Q3 2017

Nov 14, 2017

BUY
$138.36 - $147.87 $71 Million - $75.9 Million
513,329
513,329 $72.9 Million

Others Institutions Holding SYK

About STRYKER CORP


  • Ticker SYK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 378,320,992
  • Market Cap $140B
  • Description
  • Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...
More about SYK
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.